{"id":523,"date":"2023-09-26T14:11:23","date_gmt":"2023-09-26T12:11:23","guid":{"rendered":"https:\/\/www.acer-catalunya.org\/?p=523"},"modified":"2023-09-26T14:14:12","modified_gmt":"2023-09-26T12:14:12","slug":"el-vhio-suneix-a-altres-set-institucions-internacionals-en-un-consorci-liderat-per-amgen-per-accelerar-el-desenvolupament-i-laplicacio-de-noves-terapies-en-el-tractament-del-cancer","status":"publish","type":"post","link":"https:\/\/www.acer-catalunya.org\/en\/el-vhio-suneix-a-altres-set-institucions-internacionals-en-un-consorci-liderat-per-amgen-per-accelerar-el-desenvolupament-i-laplicacio-de-noves-terapies-en-el-tractament-del-cancer\/","title":{"rendered":"VHIO joins seven other international institutions in a consortium led by AMGEN to accelerate the development and application of new therapies in the treatment of cancer"},"content":{"rendered":"\n<p>Amgen (NASDAQ:AMGN) today announced the launch of Amgen Partners of Choice (APoC), a new network that brings together Amgen\u2019s oncology research and development experts and world-class clinical leaders at eight research centers across the globe. The APoC member institutions are Asan Medical Center (Seoul, South Korea), Dana-Farber Cancer Institute (Boston, Mass.), Essen University Hospital (Essen, Germany), Institute Gustave Roussy (Paris, France), Memorial Sloan Kettering Cancer Center (New York, N.Y.), Peter MacCallum Cancer Centre (Melbourne, Australia), Princess Margaret Cancer Centre (Toronto, Canada) and Vall d\u2019Hebron Institute of Oncology (Barcelona, Spain). As part of Amgen\u2019s mission to improve care through partnerships across the healthcare ecosystem, the network fosters academic collaboration to advance new treatment options for patients with the greatest unmet needs.<\/p>\n\n\n\n<p>\u201cWe have a big goal \u2013 to make profound differences in changing the standard of cancer care \u2013 and we are committed to doing that through collaboration,\u201d said Jean-Charles Soria, MD, PhD, senior vice president, Research and Development at Amgen. \u201cThrough Amgen Partners of Choice, we hope to foster earlier, deeper, and more frequent academic collaboration to fuel quicker progress for patients facing complex, difficult-to-treat cancers.\u201d<\/p>\n\n\n\n<p>The network aims to create multiple collaboration channels globally with the goal of expediting the transition of new, transformational programs to leaders in the clinic. Current APoC projects are focused on select disease areas and tumor types including thoracic, gastrointestinal, and genitourinary cancers.<\/p>\n\n\n\n<p><a href=\"https:\/\/vhio.net\/2023\/09\/21\/vhio-joins-seven-other-international-institutions-in-a-consortium-led-by-amgen-to-accelerate-the-development-and-application-of-new-therapies-in-the-treatment-of-cancer\/\">To know more&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amgen (NASDAQ:AMGN) today announced the launch of Amgen Partners of Choice (APoC), a new network that brings together Amgen\u2019s oncology research and development experts and world-class clinical leaders at eight research centers across the globe. The APoC member institutions are Asan Medical Center (Seoul, South Korea), Dana-Farber Cancer Institute (Boston, Mass.), Essen University Hospital (Essen, &#8230; <a title=\"VHIO joins seven other international institutions in a consortium led by AMGEN to accelerate the development and application of new therapies in the treatment of cancer\" class=\"read-more\" href=\"https:\/\/www.acer-catalunya.org\/en\/el-vhio-suneix-a-altres-set-institucions-internacionals-en-un-consorci-liderat-per-amgen-per-accelerar-el-desenvolupament-i-laplicacio-de-noves-terapies-en-el-tractament-del-cancer\/\" aria-label=\"More on VHIO joins seven other international institutions in a consortium led by AMGEN to accelerate the development and application of new therapies in the treatment of cancer\">Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":524,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[18],"tags":[38,44,43,34,69,53],"post_formats":[],"AFP_featured_media_urls":{"full":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default.jpg",1170,540,false],"thumbnail":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-150x150.jpg",150,150,true],"medium":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-300x138.jpg",300,138,true],"medium_large":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-768x354.jpg",768,354,true],"large":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-1024x473.jpg",1024,473,true]},"AFP_attachments":{"full":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default.jpg",1170,540,false],"thumbnail":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-150x150.jpg",150,150,true],"medium":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-300x138.jpg",300,138,true],"medium_large":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-768x354.jpg",768,354,true],"large":["https:\/\/www.acer-catalunya.org\/wp-content\/uploads\/2023\/09\/Banner-web-VHIO-1300-\u00d7-600-px-17-thegem-blog-default-1024x473.jpg",1024,473,true]},"AFP_videos":[],"AFP_video_blocks":"","AFP_category_names":["News"],"_links":{"self":[{"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/posts\/523"}],"collection":[{"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/comments?post=523"}],"version-history":[{"count":3,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/posts\/523\/revisions"}],"predecessor-version":[{"id":527,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/posts\/523\/revisions\/527"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/media\/524"}],"wp:attachment":[{"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/media?parent=523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/categories?post=523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/tags?post=523"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/www.acer-catalunya.org\/en\/wp-json\/wp\/v2\/post_formats?post=523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}